Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new, controlled ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced plans to advance development of ...

Please provide your email address to receive an email when new articles are posted on . The introduction of additional neflamapimod in an open-label extension led to significant clinical improvements.

She looked at me with tears in her eyes, and I said, “Isn’t it nice to love someone so much that saying goodbye is so hard?” Her face relaxed, as if through the disease she was able to grasp a moment ...

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on neflamapimod treatment for DLB New data demonstrating ...

Please provide your email address to receive an email when new articles are posted on . In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association ...

Researchers have pinpointed one of the brain’s “early warning signs” of dementia and Parkinson’s disease. According to the findings, this symptom can appear eight years before diagnosis.

After her mom's diagnosis of Lewy body dementia, a Lincoln woman said she noticed there was a lack of culturally diverse support options in Nebraska. Now, she's working to raise awareness and be part ...

Jackie Bezos, Jeff Bezos' mother and one of the first investors in Amazon, passed away at the age of 78 on Thursday (August 14, 2025) in Miami. Bezos said on social media that his mother had Lewy body ...